Bicocca Open Archive

Logo unimib boa
LOCATELLI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.637
AS - Asia 7.297
EU - Europa 5.519
SA - Sud America 954
AF - Africa 156
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.189
SG - Singapore 2.279
CN - Cina 1.592
VN - Vietnam 1.429
IT - Italia 1.113
HK - Hong Kong 904
DE - Germania 828
RU - Federazione Russa 805
BR - Brasile 712
SE - Svezia 531
IE - Irlanda 519
UA - Ucraina 501
CA - Canada 365
GB - Regno Unito 350
IN - India 238
FR - Francia 222
FI - Finlandia 174
AT - Austria 121
KR - Corea 118
BD - Bangladesh 105
ID - Indonesia 97
TR - Turchia 96
AR - Argentina 84
IQ - Iraq 82
NL - Olanda 60
DK - Danimarca 54
ZA - Sudafrica 51
PL - Polonia 49
MX - Messico 48
CO - Colombia 47
PK - Pakistan 46
SA - Arabia Saudita 45
BE - Belgio 43
EC - Ecuador 41
JP - Giappone 39
ES - Italia 35
PH - Filippine 34
CH - Svizzera 29
MY - Malesia 25
UZ - Uzbekistan 25
BG - Bulgaria 22
CL - Cile 17
KE - Kenya 17
MA - Marocco 17
NP - Nepal 17
TN - Tunisia 17
VE - Venezuela 16
AU - Australia 15
LB - Libano 13
PY - Paraguay 13
EG - Egitto 12
EU - Europa 11
PE - Perù 11
TW - Taiwan 11
CZ - Repubblica Ceca 10
OM - Oman 10
AL - Albania 9
AZ - Azerbaigian 9
IL - Israele 9
IR - Iran 9
KZ - Kazakistan 9
PS - Palestinian Territory 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 8
JO - Giordania 8
EE - Estonia 7
HN - Honduras 7
JM - Giamaica 7
KG - Kirghizistan 7
RO - Romania 7
TH - Thailandia 7
CR - Costa Rica 6
DZ - Algeria 5
GT - Guatemala 5
PT - Portogallo 5
AO - Angola 4
BO - Bolivia 4
HR - Croazia 4
LT - Lituania 4
RS - Serbia 4
SC - Seychelles 4
BY - Bielorussia 3
HU - Ungheria 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SN - Senegal 3
BH - Bahrain 2
CD - Congo 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ML - Mali 2
MR - Mauritania 2
MU - Mauritius 2
Totale 27.571
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Singapore 1.314
Ashburn 1.197
Woodbridge 1.090
Fairfield 979
Hong Kong 893
Houston 789
Chandler 736
Wilmington 720
San Jose 663
Frankfurt am Main 562
Jacksonville 506
Dublin 496
Seattle 446
Ho Chi Minh City 435
Hanoi 346
Dearborn 323
Cambridge 310
Beijing 309
Milan 306
New York 273
Chicago 216
Princeton 211
Santa Clara 198
Hefei 179
Los Angeles 178
Toronto 160
Dallas 147
The Dalles 141
Nanjing 136
Seoul 108
Vienna 106
Lauterbourg 100
Lawrence 87
Altamura 86
Lachine 82
Shanghai 82
Moscow 79
Council Bluffs 77
Buffalo 75
Jakarta 74
São Paulo 67
Helsinki 65
Da Nang 63
Boardman 58
Guangzhou 53
Haiphong 53
London 52
Detroit 48
Rome 46
Brussels 41
Nanchang 41
San Diego 41
Falls Church 40
Baghdad 37
Munich 36
Hebei 32
Orem 32
Andover 29
Nuremberg 29
Tokyo 29
Biên Hòa 27
Changsha 27
Kent 27
Shenyang 27
Mountain View 26
Rio de Janeiro 26
Warsaw 26
Pune 25
Tianjin 25
Ha Long 24
Huizen 24
Elora 23
Fremont 23
San Francisco 22
Tashkent 22
Salt Lake City 21
Atlanta 20
Denver 20
Grafing 20
Hải Dương 20
Jiaxing 20
Philadelphia 20
Bologna 19
Can Tho 19
Dhaka 19
Jinan 19
Ottawa 19
Renton 19
Turku 19
Poplar 18
Riyadh 18
Stockholm 18
Brooklyn 17
Hangzhou 17
Kunming 17
Quận Bình Thạnh 17
Jeddah 16
Medellín 16
Monza 16
Totale 18.530
Salva come PNG Salva come JPEG
Nome #
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 490
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 450
Growth hormone secretagogues and the regulation of calcium signaling in muscle 442
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 437
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 389
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 388
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 383
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 372
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 349
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 345
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 341
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 335
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 320
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 315
Neurotrophic and neuroregenerative effects of GH/IGF1 308
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 302
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 301
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 299
Feeding behavior during long-term hexarelin administration in young and old rats 297
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 297
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 294
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 288
Ghrelin in gastroenteric pathophysiology 285
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 285
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 283
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 282
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 281
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 277
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 273
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 270
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 269
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 269
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 268
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 267
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 262
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 261
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 261
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 257
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 256
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 252
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 250
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 247
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 246
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 245
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 244
Somatotropic dysregulation in old mammals 243
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 242
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 242
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 242
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 241
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 239
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 238
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 238
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 236
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 234
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 233
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 231
La valutazione delle attività di tirocinio pratico da parte dei tutori 229
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 227
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 226
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 226
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 221
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 219
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 218
Growth hormone-inhibiting activity of cortistatin in the rat 217
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 217
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 216
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 216
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 215
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 214
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 214
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 213
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 212
Ghrelin expression in gut endocrine growths 211
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 211
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 209
Low dose of insulin for assessment of growth hormone and cortisol release in short children 207
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 207
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 205
Growth hormone-independent cardioprotective effects of hexarelin in the rat 202
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 200
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 199
La somatopausa: nuove prospettive terapeutiche 199
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 199
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 199
Pyruvate and satiety: can we fool the brain? 197
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 197
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 196
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 195
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 192
Testosterone a key factor in gender related metabolic syndrome 191
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 190
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 189
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 188
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action 188
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 185
L’accesso a Medicina. Best evidence-based practice, requisito indispensabile per una ipotesi di “Processo di Selezione” centrato sulla realtà formativa italiana e di caratura internazionale 183
New active series of growth hormone secretagogues 180
Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes 179
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 178
Totale 25.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 0 0 0 0 0 0 0 0 83 131
2021/20221.199 63 109 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20253.743 215 352 234 239 349 161 271 223 257 519 281 642
2025/20269.246 1.467 815 695 968 984 506 1.350 464 875 775 347 0
Totale 28.028